Import licence for added value

Logistics Park Rhein-Main

Import licence offers new added value for the pharmaceutical industry!

In January 2017, the import licence pursuant to section 72 AMG (German Medicinal Products Act), as well as the customs accreditations pursuant to section 73 AMG and the GMP certificate, were awarded for our Logistics Park Rhein-Main (LPRM) site in Biebesheim near Darmstadt.

This forms the basis for expanding our offer for pharmaceutical manufacturers at the LPRM. Even greater involvement in the pharmaceutical customer’s value-added chain is now possible. This generates further added value for a partnership-based collaboration.

The LPRM has been operating as EU hub since February 2017. Finished pharmaceutical products, active ingredients and intermediates are imported from non-member countries (including non-MRA countries). The competent person under the terms of section 14 AMG (German Medicinal Products Act), the head of manufacture and the head of quality control play an important role. The GMP certificate awarded shows compliance with good manufacturing practice (GMP). GMP must be followed when importing pharmaceutical products for human use as the AMG does not distinguish between manufacture and import in this regard.

Do you want to transfer import activities to Germany or are you planning on outsourcing areas of your pharmaceutical manufacture that have an interface with logistics? Then we are the right partner and service provider!

Your contact

Simone Ferrante

Head Quality & Regulatory Affairs

+49 7761 9215-140

Write email

Go back